EX-FILING FEES 7 exhibit_107.htm EXHIBIT 107

Exhibit 107
Calculation of Filing Fee Tables

| Form S-1 |
| (Form Type) |

| CHEMOMAB THERAPEUTICS LTD. |
| (Exact Name of Registrant as Specified in its Charter) |

Table 1: Newly Registered and Carry Forward Securities

|  | Security Type |  | Security Class Title |  | Fee Calculation or Carry Forward Rule |  | Maximum Aggregate Offering Price(1)(2) |  |  | Fee Rate |  | Amount of Registration Fee |
Newly Registered Securities |
Fees to be Paid |  | Equity |  | American Depositary Shares (2) |  | (1) |  | $ | 15,000,000.00 |  |  | $ | .0001102 |  | $ | 1,653.00 |
Fees to be Paid |  | Other |  | Warrants to Purchase American Depositary Shares (2) |  | (3) |  |  |  |  |  |  |  |  |  |  |
Fees to be Paid |  | Equity |  | American Depositary Shares issuable upon exercise of warrants (2) |  | (1) |  | $ | 15,000,000.00 |  |  | $ | .0001102 |  | $ | 1,653.00 |
|  | Total Offering Amounts |  |  | $ | 30,000,000.00 |  |  |  |  |  | $ | 3,306.00 |
|  | Total Fees Previously Paid |  |  |  |  |  |  |  |  |  | $ | 2,534.60 |
|  | Total Fee Offsets |  |  |  |  |  |  |  |  |  |  | - |
|  | Net Fee Due |  |  |  |  |  |  |  |  |  | $ | 771.40 |

| (1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.
| (2) | Each ADS represents twenty (20) ordinary shares of the registrant. ADSs issuable upon deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-229522).
| (3) | Calculated in accordance with Rule 457(g) under the Securities Act, because the ADSs of the registrant underlying the warrants are registered hereby.